These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21362619)

  • 1. A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore.
    Streit AK; Netter MF; Kempf F; Walecki M; Rinné S; Bollepalli MK; Preisig-Müller R; Renigunta V; Daut J; Baukrowitz T; Sansom MS; Stansfeld PJ; Decher N
    J Biol Chem; 2011 Apr; 286(16):13977-84. PubMed ID: 21362619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels.
    Ramírez D; Arévalo B; Martínez G; Rinné S; Sepúlveda FV; Decher N; González W
    Mol Pharm; 2017 Jul; 14(7):2197-2208. PubMed ID: 28494157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the A293 (AVE1231) Binding Site in the Cardiac Two-Pore-Domain Potassium Channel TASK-1: a Common Low Affinity Antiarrhythmic Drug Binding Site.
    Wiedmann F; Kiper AK; Bedoya M; Ratte A; Rinné S; Kraft M; Waibel M; Anad P; Wenzel W; González W; Katus HA; Decher N; Schmidt C
    Cell Physiol Biochem; 2019; 52(5):1223-1235. PubMed ID: 31001961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.
    Chokshi RH; Larsen AT; Bhayana B; Cotten JF
    Mol Pharmacol; 2015 Nov; 88(5):926-34. PubMed ID: 26268529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.
    Rinné S; Kiper AK; Schlichthörl G; Dittmann S; Netter MF; Limberg SH; Silbernagel N; Zuzarte M; Moosdorf R; Wulf H; Schulze-Bahr E; Rolfes C; Decher N
    J Mol Cell Cardiol; 2015 Apr; 81():71-80. PubMed ID: 25655935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of volatile and intravenous anesthetics on the activity of human TASK-1.
    Putzke C; Hanley PJ; Schlichthörl G; Preisig-Müller R; Rinné S; Anetseder M; Eckenhoff R; Berkowitz C; Vassiliou T; Wulf H; Eberhart L
    Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1319-26. PubMed ID: 17699638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats.
    Cotten JF
    Anesth Analg; 2013 Apr; 116(4):810-6. PubMed ID: 23460565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.
    Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1003-16. PubMed ID: 22790794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channels.
    Gierten J; Hassel D; Schweizer PA; Becker R; Katus HA; Thomas D
    Biochim Biophys Acta; 2012 Jan; 1818(1):33-41. PubMed ID: 21963410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels.
    Staudacher K; Staudacher I; Ficker E; Seyler C; Gierten J; Kisselbach J; Rahm AK; Trappe K; Schweizer PA; Becker R; Katus HA; Thomas D
    Br J Pharmacol; 2011 Jul; 163(5):1099-110. PubMed ID: 21410455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
    Seebohm G; Chen J; Strutz N; Culberson C; Lerche C; Sanguinetti MC
    Mol Pharmacol; 2003 Jul; 64(1):70-7. PubMed ID: 12815162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lower X-gate in TASK channels traps inhibitors within the vestibule.
    Rödström KEJ; Kiper AK; Zhang W; Rinné S; Pike ACW; Goldstein M; Conrad LJ; Delbeck M; Hahn MG; Meier H; Platzk M; Quigley A; Speedman D; Shrestha L; Mukhopadhyay SMM; Burgess-Brown NA; Tucker SJ; Müller T; Decher N; Carpenter EP
    Nature; 2020 Jun; 582(7812):443-447. PubMed ID: 32499642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone.
    Gierten J; Ficker E; Bloehs R; Schweizer PA; Zitron E; Scholz E; Karle C; Katus HA; Thomas D
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):261-70. PubMed ID: 19777211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5).
    Kindler CH; Paul M; Zou H; Liu C; Winegar BD; Gray AT; Yost CS
    J Pharmacol Exp Ther; 2003 Jul; 306(1):84-92. PubMed ID: 12660311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels.
    Decher N; Pirard B; Bundis F; Peukert S; Baringhaus KH; Busch AE; Steinmeyer K; Sanguinetti MC
    J Biol Chem; 2004 Jan; 279(1):394-400. PubMed ID: 14578345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis for an allosteric inhibition of K
    Rinné S; Kiper AK; Vowinkel KS; Ramírez D; Schewe M; Bedoya M; Aser D; Gensler I; Netter MF; Stansfeld PJ; Baukrowitz T; Gonzalez W; Decher N
    Elife; 2019 Feb; 8():. PubMed ID: 30803485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine.
    Ramírez D; Bedoya M; Kiper AK; Rinné S; Morales-Navarro S; Hernández-Rodríguez EW; Sepúlveda FV; Decher N; González W
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandem pore domain halothane-inhibited K+ channel subunits THIK1 and THIK2 assemble and form active channels.
    Blin S; Chatelain FC; Feliciangeli S; Kang D; Lesage F; Bichet D
    J Biol Chem; 2014 Oct; 289(41):28202-12. PubMed ID: 25148687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional characterization of zebrafish K
    Staudacher I; Illg C; Gierten J; Seehausen S; Schweizer PA; Katus HA; Thomas D
    Eur J Pharmacol; 2018 Jul; 831():94-102. PubMed ID: 29753045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Small-Molecule Compound Selectively Activates K2P Channel TASK-3 by Acting at Two Distant Clusters of Residues.
    Tian F; Qiu Y; Lan X; Li M; Yang H; Gao Z
    Mol Pharmacol; 2019 Jul; 96(1):26-35. PubMed ID: 31015283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.